Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents: A pilot study

被引：0
作者：
Hasan, Fuad
Alsarraf, Khalid
Qabandi, Wafa
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A840 / A840
页数：1
相关论文
共 50 条
  • [41] Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
    Taura, Naota
    Ichikawa, Tatsuki
    Miyaaki, Hisamitsu
    Kadokawa, Yoshiko
    Tsutsumi, Takuya
    Tsuruta, Shotaro
    Kato, Yuji
    Inoue, Osami
    Kinoshita, Noboru
    Ohba, Kazuo
    Kato, Hiroyuki
    Ohata, Kazuyuki
    Masuda, Junichi
    Hamasaki, Keisuke
    Yatsuhashi, Hiroshi
    Nakao, Kazuhiko
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [42] Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Fukui, Hiroyuki
    Inui, Yoshiaki
    Hijioka, Taizo
    Inada, Masami
    Kaytayama, Kazuhiro
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Kato, Michio
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 604 - 611
  • [43] The influence of cigarette smoking on response to treatment with pegylated interferon alfa-2b and ribavirin in patients with chronic hepatitis C
    Pauly, Mary P.
    Sheinbaum, Alan J.
    Szpakowski, Jean-Luc I.
    Ready, Joanna B.
    Brown, Robert S.
    Freilich, Bradley
    Afdhal, Nezam
    Kwo, Paul
    Santoro, John
    Becker, Scott
    Jacobson, Ira
    Griffel, Louis
    Brass, Clifford
    GASTROENTEROLOGY, 2006, 130 (04) : A286 - A286
  • [44] Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.
    Wong, JB
    Siebert, U
    Manns, MP
    McHutchison, JG
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Rossol, S
    Ling, MH
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
  • [45] Standard and pegylated interferon alfa-2b plus ribavirin as initial treatment for HCV genotype 2 chronic hepatitis: Analysis of a large single center cohort
    Rumi, Mariagrazia
    Aghemo, Alessio
    D'Ambrosio, Roberta
    Ronchi, Guido
    Gallus, Silvano
    Colombo, Massimo
    HEPATOLOGY, 2006, 44 (04) : 334A - 334A
  • [46] Pegylated interferon alfa-2b plus ribavirin in patients with genotype 1 chronic hepatitis C with a slow virologic response: An early enrollers analysis of the success study
    Buti, Maria
    Lurie, Yoav
    Blokhina, Natalia
    Teuber, Gerlinde
    Halota, Waldermar
    Sumskiene, Jolanta
    Vozianova, Zhanna
    Wong, Florence
    Winkler, Robert
    Esteban, Rafael
    HEPATOLOGY, 2006, 44 (04) : 342A - 342A
  • [47] Treatment of chronic hepatitis C with pegylated interferon alfa-2b and ribavirin in patients under methadone: A prospective; Controlled study.
    Mauss, S
    Berger, F
    Goelz, J
    Kaiserdamm, P
    Jacob, B
    Schmutz, G
    HEPATOLOGY, 2002, 36 (04) : 569A - 569A
  • [48] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy
    Chousterman, N
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
  • [49] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
  • [50] Induction of Autoimmune Hepatitis by Pegylated Interferon Alfa-2b in Chronic Hepatitis C
    Loerke, Julia
    Erhardt, Andreas
    Haeussinger, Dieter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) : A20 - A20
12345